Silexion Therapeutics - Warrants(14/08/2029) Total Current Liabilities

As of the most recent data (June 2026), SLXNW shows a total current liabilities of $4M. That compares with $2.2M in the prior-year period — up 85.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLXNW's total current liabilities is now $4M (was $2.2M) — a 85.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Silexion Therapeutics - Warrants(14/08/2029) is outperforming or lagging.

Tracking SLXNW's total current liabilities over time shows whether Silexion Therapeutics - Warrants(14/08/2029) is scaling, shrinking, or reshaping that part of the business. The current reading is $4M That compares with $2.2M in the prior-year period — up 85.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Silexion Therapeutics - Warrants(14/08/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $4M) with ownership activity and broader fundamentals.